...
首页> 外文期刊>Molecular and Cellular Endocrinology >Protein kinase C, rather than protein kinase A is involved in follicle-stimulating hormone-mediated meiotic resumption of mouse cumulus cell-enclosed oocytes in hypoxanthine-supplemented medium.
【24h】

Protein kinase C, rather than protein kinase A is involved in follicle-stimulating hormone-mediated meiotic resumption of mouse cumulus cell-enclosed oocytes in hypoxanthine-supplemented medium.

机译:在补充黄嘌呤的培养基中,蛋白激酶C而不是蛋白激酶A参与了卵泡刺激激素介导的小鼠卵丘细胞封闭卵母细胞的减数分裂恢复。

获取原文
获取原文并翻译 | 示例

摘要

It has been reported that protein kinase C (PKC) activation participated in the porcine and bovine oocyte maturation, but not in mouse oocyte maturation in vitro. In the present study, the activators and inhibitors of protein kinase A (PKA) (forskolin, CDPKI and MDL-12230A) or PKC (PMA, staurosporine and sphingosine) were used to investigate the in vitro effect of PKA or PKC on spontaneous murine oocyte maturation, oocyte resumption of meiosis from HX inhibiting medium (medium+HX), and follicle stimulating hormone (FSH)-induced oocyte maturation. The results showed that when cumulus cell enclosed oocytes (CEOs) or denuded oocytes (DOs) were cultured for 24 h in the medium supplemented with forskolin (5 microM), an activator of adenylate cyclase, the spontaneous oocyte maturation were inhibited. A transient exposure (2 h) to forskolin (2-10 microM) in the medium+HX, and then transferred to a new medium+HX for the further culture, stimulated CEO resumption of meiosis. CDPKI (10(-10)-10(-6) M), an inhibitor of PKA, also stimulated oocyte meiotic maturation of CEO in the medium+HX, but not on DO. However, MDL-12230A (10(-12)-10(-9) M), an inhibitor of adenylate cyclase, did not promote oocyte maturation in HX arrested CEO. CDPKI (10(-10)-10(-6) M) or MDL-12230A (10(-12)-10(-9) M) had no effect on FSH-stimulated oocyte meiotic resumption, except at high doses of CDPKI (10(-7)-10(-6) M) or MDL-12230A (10(-9) M) which inhibited the FSH-induced formation of the first polar body (PB1). An activator of PKC, PMA (10(-11)-10(-7) M) dose-dependently inhibited spontaneous oocyte maturation of CEO or DO. Inhibitors of PKC, staurosporine (10(-9)-10(-6) M) or sphingosine (10(-8)-10(-5) M) induced oocytes in CEOs to resume meiosis in the presence of HX in a dose dependent manner, but had no effect on DOs. FSH (50IU/L) stimulated mouse oocytes in CEOs to override the arrest of HX and resume meiosis, while PMA, at the level of 10(-8)-10(-6) M, dramatically inhibited the stimulatory effect of FSH. These results indicate that PKC or PKA may be implicated in the regulation of mouse oocyte maturation. Thus while sustained high level of cAMP or PKA inhibit the resumption of meiosis, a transient rise in cAMP or PKA levels promotes oocyte maturation. The activation of PKC can also block oocyte meiotic resumption. Thus the inactivation of PKC, instead of the transient rise of PKA activity, appears to be involved in the process of FSH-mediated oocyte meiotic maturation.
机译:据报道,蛋白激酶C(PKC)的激活参与了猪和牛卵母细胞的成熟,但没有参与小鼠卵母细胞的体外成熟。在本研究中,蛋白激酶A(PKA)(毛喉素,CDPKI和MDL-12230A)或PKC(PMA,星形孢菌素和鞘氨醇)的激活剂和抑制剂用于研究PKA或PKC对自发鼠卵母细胞的体外作用成熟,卵母细胞从HX抑制培养基(中等+ HX)恢复减数分裂以及卵泡刺激素(FSH)诱导的卵母细胞成熟。结果表明,当在补充了福斯高林(5 microM)的腺苷酸环化酶激活剂的培养基中培养卵丘细胞封闭的卵母细胞(CEO)或裸露的卵母细胞(DOs)24小时后,卵母细胞的自发成熟受到抑制。在培养基+ HX中短暂暴露于佛司可林(2-10 microM)中(2小时),然后转移到新的培养基+ HX中进行进一步培养,刺激了CEO恢复减数分裂。 CDPKI(10(-10)-10(-6)M)是PKA的抑制剂,在培养基+ HX中也刺激CEO的卵母细胞减数分裂成熟,但在DO上则没有。但是,MDL-12230A(10(-12)-10(-9)M),一种腺苷酸环化酶的抑制剂,不能促进HX被捕CEO的卵母细胞成熟。 CDPKI(10(-10)-10(-6)M)或MDL-12230A(10(-12)-10(-9)M)对FSH刺激的卵母细胞减数分裂恢复没有影响,除非在高剂量的CDPKI下(10(-7)-10(-6)M)或MDL-12230A(10(-9)M)抑制FSH诱导的第一极体(PB1)的形成。 PKC,PMA(10(-11)-10(-7)M)的激活剂剂量依赖性地抑制CEO或DO的自发卵母细胞成熟。在HX存在下,一定剂量的PKC,星形孢菌素(10(-9)-10(-6)M)或鞘氨醇(10(-8)-10(-5)M)的抑制剂诱导CEO卵母细胞恢复减数分裂依赖的方式,但对DO没有影响。 FSH(50IU / L)刺激CEO中的小鼠卵母细胞超越HX的阻滞并恢复减数分裂,而PMA的水平为10(-8)-10(-6)M则显着抑制FSH的刺激作用。这些结果表明PKC或PKA可能与小鼠卵母细胞成熟的调控有关。因此,尽管持续高水平的cAMP或PKA抑制减数分裂的恢复,但cAMP或PKA的短暂升高会促进卵母细胞的成熟。 PKC的激活还可以阻止卵母细胞减数分裂的恢复。因此,PKC的失活,而不是PKA活性的瞬时升高,似乎与FSH介导的卵母细胞减数分裂成熟过程有关。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号